People · Operator
Named in public records as an officer, director or promoter · active 2021–2021 · Healthtech
| Company | Role | Sector | Stage | Raised · real | Value · est | Tied |
|---|---|---|---|---|---|---|
| binx health Ltd | — | Healthtech | Series D+ | $103.6M | $2.2B | 2021 |
Martin R. Munchbach at the center, the companies they're named on, and every other operator named alongside them — an interlock map of shared founding teams, boards and funds. Name-matched, so treat as a research lead.
People named alongside Martin R. Munchbach on the same companies — an interlock signal (shared founding team, board, or fund). Name-matched, so verify before acting.
| Operator | Shared | Their companies |
|---|---|---|
| Jeffrey R. Luber | 1 | 2 |
| David R. King | 1 | 2 |
| Andrew R. Goldman | 1 | 1 |
| Anna R. Dixon | 1 | 1 |
| Jihua R. Wang | 1 | 1 |
| Joachim R. Rothe | 1 | 1 |
| Gail R. Marcus | 1 | 1 |
| Marc R. Jones | 1 | 1 |
| Mark R. Quick | 1 | 1 |
| Scott R. Moonly | 1 | 1 |
| Stanley R. Lapidus | 1 | 1 |
People are matched by normalized name across records; a common name may merge distinct individuals. Treat as a research lead, the same way modeled valuations are directional, not quoted.